| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Brooklyn ImmunoTherapeutics, Inc. | CEO & President, Director | Stock Option (Right to buy) | 413,700 | 11 Mar 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | 11 Mar 2022 | 1 | $0 | 4/A | CEO & President, Director | 17 Mar 2022, 21:00 |